Search results
Mar 5, 2024 · Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing novel therapies that harness the body's immune system to bring...
Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to...
Dec 5, 2023 · News provided by. Dragonfly Therapeutics, Inc. Dec 05, 2023, 10:00 ET. Share this article. The company announces the first patient dosed in a Phase 1/1b clinical trial evaluating its novel IL-2...
Oct 18, 2021 · Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel technology to harness the body's...
Dec 8, 2022 · Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel bispecific antibody technology to...
Dec 5, 2023 · Dragonfly Therapeutics, Inc., a clinical stage biotechnology company developing novel immunotherapies, today announced it recently dosed its first patient in a Phase 1/1b study of the Company's...
Nov 1, 2022 · Dragonfly Announces First Patient Dosed in Clinical Trial with Merck Evaluating Solid Tumor Target. Milestone payment to Dragonfly is triggered by dosing of first patient in Phase 1 clinical trial Dragonfly Therapeutics, Inc.... Read Article. March 31, 2022.
